ADD | MCI-AD | FTLD | HC | ||
---|---|---|---|---|---|
n (%f) | 119 (59.7) | 101 (47.5) | 34 (58.8) | 58 (34.5) | |
Age [years] | M (SD) | 66.4 (9.5) | 68.4 (10.0) | 66.2 (8.6) | 59.1 (13.7) |
MD (IQR) | 67 (60–73) | 72 (82–76) | 64.0 (59.3–74.0) | 60.5 (51.0–70.8) | |
Range | 40–89 | 41–84 | 46–83 | 30–85 | |
MMSE [points] | M (SD) | 19.5 (4.8) | 26.8 (1.3) | 20.5 (6.6) | 29.5 (0.7) |
MD (IQR) | 21 (18–23) | 27 (60–28) | 22.5 (16.3–26.0) | 30.0 (29.0–30.0) | |
Range | 1–24 | 25–30 | 2–30 | 28–30 | |
CSF lactate [mmol/l] | M (SD) | 1.75 (0.25) | 1.83 (0.24) | 1.79 (0.23) | 1.73 (0.31) |
MD (IQR) | 1.72 (1.60–1.90) | 1.80 (1.69–1.95) | 1.80 (1.63–1.93) | 1.69 (1.50–1.90) | |
Range | 1.20–1.70 | 1.30–2.60 | 1.30–2–27 | 1.10–2.70 | |
Albumin CSF/serum | M (SD) | 6.82 (2.63) | 6.61 (2.56) | 6.23 (2.19) | 6.91 (2.92) |
MD (IQR) | 6.38 (4.87–8.22) | 5.88 (4.80–7.56) | 5.81 (4.78–6.80) | 5.94 (4.83–8.32) | |
Range | 2.55–14.40 | 2.98–13.20 | 3.32–13.10 | 2.68–14.30 | |
CSF Aβ42 [pg/nl] | M (SD) | 464 (116) | 452 (110) | 662 (438) | 1029 (252) |
MD (IQR) | 471 (393–552) | 469 (368–551) | 662 (470–975) | 1029 (816–1219) | |
Range | 226–649 | 182–638) | 334–2352 | 670–1714 | |
CSF t-Tau [pg/nl] | M (SD) | 797 (638) | 554 (360) | 685 (706) | 262 (101) |
MD (IQR) | 630 (397–991) | 461 (342–680) | 451 (331–659) | 246 (183–314) | |
Range | 122–4635 | 37–1708 | 70–3600 | 108–551 |